Condition
Non-Muscle Invasive Bladder Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Non-Muscle Invasive Bladder Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Ukraine (1)). By phase: Phase 1 (1), Phase 1/2 (1), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Non-Muscle Invasive Bladder Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Intravesical UGN-501 for Recurrent NMIBC (Phase 1, dose-escalation) | Phase 1 | Queen Creek, Arizona and 14 other locations | Recruiting | Jul 24, 2026 |
| TARA-002 vs chemotherapy for high-grade non-muscle invasive bladder cancer in adults not previously treated with BCG | Phase 3 | Queen Creek, Arizona and 10 other locations | Recruiting | Mar 18, 2026 |
| Body position and bladder hold time during BCG treatment for non-muscle invasive bladder cancer | Phase 4 | Columbus, Ohio | Recruiting | Mar 16, 2026 |
| Cruciferous vegetable eating program to reduce recurrence and progression in early-stage bladder cancer | Phase 2 | Buffalo, New York | Recruiting | Dec 13, 2024 |
| In-home chemotherapy for bladder cancer treatment | Phase 1/2 | Jacksonville, Florida | Recruiting | Nov 26, 2024 |
All recruiting trials (5)
-
Intravesical UGN-501 for Recurrent NMIBC (Phase 1, dose-escalation)
This study tests whether UGN-501 can be safely given into the bladder to treat adults with recurrent non-muscle invasive bladder cancer.
-
TARA-002 vs chemotherapy for high-grade non-muscle invasive bladder cancer in adults not previously treated with BCG
A phase 3 study tests whether TARA-002 can help adults with high-grade non-muscle invasive bladder cancer who haven’t had BCG, comparing it to standard intravesical chemotherapy.
-
Body position and bladder hold time during BCG treatment for non-muscle invasive bladder cancer
This project will test whether lying down or sitting during BCG treatment changes how long the medicine stays in the bladder for people with intermediate- or high-risk non-muscle invasive bladder cancer.
-
Cruciferous vegetable eating program to reduce recurrence and progression in early-stage bladder cancer
This trial will test whether a behavioral program that increases cruciferous vegetable intake (like broccoli, cabbage, kale) and a maintenance component can lower recurrence or progression in adults with early-stage non-muscle invasive bladder cancer.
-
In-home chemotherapy for bladder cancer treatment
This study tests whether giving chemotherapy for bladder cancer at home is safe and more convenient for patients compared to getting it in a clinic.
Related topics
Quick answers
How many Non-Muscle Invasive Bladder Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Ukraine (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.